Literature DB >> 8945546

Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.

J Fujii1, Y Kinoshita, T Kita, A Higure, T Takeda, N Tanaka, S Yoshida.   

Abstract

When rabbits were given intravenously purified verotoxin 2 (VT2) at 5 microg/kg of body weight, they developed hemorrhagic diarrhea, flaccid paresis, an ataxic gait, an opisthotonic posture, and convulsions. To examine the effects of VT2 toxemia on the rabbit central nervous system, magnetic resonance imaging and ultrastructural studies were performed. At 24, 57, and 80 h after injection of VT2 into 12 rabbits, T2-weighted images of the central nervous system were obtained. The initial lesion was noted at 24 h in the hypothalamic areas of all experimental animals. At 57 h, the T2 value increased in the medulla of the cerebral hemisphere or the hippocampus, with a brain stem lesion in six rabbits (50%). The rabbits with the brain stem lesions, in which neurological signs were very severe, died within 6 days. Lesions in the cerebellar hemisphere and/or vermis were noted in four rabbits (33%) that survived more than 1 month. To better understand the pathogenesis of VT2 in these brain lesions, we examined the deterioration of the blood-brain barrier and cerebrospinal fluid-brain barrier by using horseradish peroxidase as a tracer. The tracer was detected by electron microscopy both in the subendothelial layer, including the basal lamina, and throughout the cytoplasm of the ependymal cell layer covering the ventricle after intravenous or intrathecal treatment with horseradish peroxidase. We also determined the localization of VT2 by immunoelectron microscopy and found that it was localized on edematous endothelial cells of capillaries, ependymal cells, and myelin sheaths. The present study suggests that VT2 was conveyed from the endothelial and ependymal cell layers and caused edematous changes in the rabbit brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945546      PMCID: PMC174488          DOI: 10.1128/iai.64.12.5053-5060.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.

Authors:  T J Barrett; M E Potter; I K Wachsmuth
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

2.  A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues.

Authors:  Z R Shi; S H Itzkowitz; Y S Kim
Journal:  J Histochem Cytochem       Date:  1988-03       Impact factor: 2.479

3.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

Authors:  T Waddell; S Head; M Petric; A Cohen; C Lingwood
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

4.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets.

Authors:  S Tzipori; C W Chow; H R Powell
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

6.  Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.

Authors:  T Yutsudo; N Nakabayashi; T Hirayama; Y Takeda
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

Review 7.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

8.  Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7.

Authors:  D H Francis; R A Moxley; C Y Andraos
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.

Authors:  S M Ostroff; P I Tarr; M A Neill; J H Lewis; N Hargrett-Bean; J M Kobayashi
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

10.  The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.

Authors:  M J Karnovsky
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

View more
  30 in total

1.  Toxicity of Shiga toxin 1 in the central nervous system of rabbits.

Authors:  J Fujii; Y Kinoshita; T Yutsudo; H Taniguchi; T Obrig; S I Yoshida
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Encephalopathy and exposure to Shiga toxin without evidence of haemolytic uraemic syndrome.

Authors:  Frank Ahrens; Kerstin Ludwig; Klaus Terstegge; Uwe Querfeld
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

Review 3.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

4.  The actions of Shiga toxin-2 administration into the brain on renal sympathetic nerve activity.

Authors:  Akio Nakamura; Akira Imaizumi; Takao Kohsaka; Chunlong Huang; Chunhua Huang; Edward J Johns
Journal:  Clin Exp Nephrol       Date:  2011-12-03       Impact factor: 2.801

5.  Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.

Authors:  J Balter-Seri; Y Yuhas; A Weizman; Y Nofech-Mozes; E Kaminsky; S Ashkenazi
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 6.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

7.  Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits.

Authors:  Jennifer M Ritchie; Cheleste M Thorpe; Arlin B Rogers; Matthew K Waldor
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Authors:  Marc Steinborn; Steffen Leiz; Klaus Rüdisser; Martin Griebel; Thomas Harder; Helmut Hahn
Journal:  Pediatr Radiol       Date:  2004-07-29

Review 9.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

10.  Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein.

Authors:  Jun Fujii; Katie Wood; Fumiko Matsuda; Benedito A Carneiro-Filho; Keilo H Schlegel; Takashi Yutsudo; Beth Binnington-Boyd; Clifford A Lingwood; Fumiko Obata; Kwang S Kim; Shin-ichi Yoshida; Tom Obrig
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.